Compile Data Set for Download or QSAR
Report error Found 349 Enz. Inhib. hit(s) with all data for entry = 2041
TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350908(US9796700, Compound I-2)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350911(US9796700, Compound I-5)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350913(US9796700, Compound I-7)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350915(US9796700, Compound I-9)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350916(US9796700, Compound I-10)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350919(US9796700, Compound I-13)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350921(US9796700, Compound I-15)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350923(US9796700, Compound I-17)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350924(US9796700, Compound I-18)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350925(US9796700, Compound I-19)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350927(US9796700, Compound I-20)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350929(US9796700, Compound I-307)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350932(US9796700, Compound I-23)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350946(US9796700, Compound I-36)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350947(US9796700, Compound I-37)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350948(US9796700, Compound I-38)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350950(US9796700, Compound I-40)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350951(US9796700, Compound I-310)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350952(US9796700, Compound I-41)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350953(US9796700, Compound I-42)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350954(US9796700, Compound I-43)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350957(US9796700, Compound I-46)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350958(US9796700, Compound I-47)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350959(US9796700, Compound I-48)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350964(US9796700, Compound I-53)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350965(US9796700, Compound I-54)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350966(US9796700, Compound I-55)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350975(US9796700, Compound I-64)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350978(US9796700, Compound I-68)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350979(US9796700, Compound I-69)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350980(US9796700, Compound I-70)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350981(US9796700, Compound I-71)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350986(US9796700, Compound I-76)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350987(US9796700, Compound I-77)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350996(US9796700, Compound I-86)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350998(US9796700, Compound I-88)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351000(US9796700, Compound I-90)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351001(US9796700, Compound I-91)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351002(US9796700, Compound I-92)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351005(US9796700, Compound I-95)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351008(US9796700, Compound I-98)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351012(US9796700, Compound I-102)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351013(US9796700, Compound I-103)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM50094304(CHEMBL3590118 | US9796700, Compound I-108)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351022(US9796700, Compound I-112)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351025(US9796700, Compound I-128 | US9796700, Compound I-...)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351028(US9796700, Compound I-118)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351029(US9796700, Compound I-119)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351030(US9796700, Compound I-120)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351031(US9796700, Compound I-121)
Affinity DataIC50: 100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
9/23/2019
Entry Details
Go to US Patent

Displayed 1 to 50 (of 349 total ) | Next | Last >>
Jump to: